0000899243-20-002026.txt : 20200127
0000899243-20-002026.hdr.sgml : 20200127
20200127145846
ACCESSION NUMBER: 0000899243-20-002026
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200123
FILED AS OF DATE: 20200127
DATE AS OF CHANGE: 20200127
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: McDonough John
CENTRAL INDEX KEY: 0001615937
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36571
FILM NUMBER: 20549113
MAIL ADDRESS:
STREET 1: T2 BIOSYSTEMS, INC.
STREET 2: 101 HARTWELL AVE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: T2 Biosystems, Inc.
CENTRAL INDEX KEY: 0001492674
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 204827488
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 101 HARTWELL AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 781-457-1200
MAIL ADDRESS:
STREET 1: 101 HARTWELL AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-01-23
0
0001492674
T2 Biosystems, Inc.
TTOO
0001615937
McDonough John
101 HARTWELL AVE
LEXINGTON
MA
02421
1
0
0
0
Common Stock
2020-01-23
4
S
0
57417
1.15
D
512868
D
The transaction was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on June 11, 2018.
The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $1.10 to $1.20. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each price within the range set forth in this footnote.
/s/ John Sprague, Attorney-in-fact
2020-01-27